We just received data on a new analyst forecast for $EXEL. Sean Laaman from Morgan Stanley set a price target of 50.0 for EXEL.
To track analyst ratings and price targets for $EXEL, check out Quiver Quantitative's $EXEL forecast page.
$EXEL Price Targets
Multiple analysts have issued price targets for $EXEL recently. We have seen 16 analysts offer price targets for $EXEL in the last 6 months, with a median target of $46.0.
Here are some recent targets:
- Sean Laaman from Morgan Stanley set a target price of $50.0 on 09/17/2025
- Etzer Darout from Barclays set a target price of $40.0 on 09/17/2025
- Paul Choi from Goldman Sachs set a target price of $47.0 on 09/17/2025
- Robert Burns from HC Wainwright & Co. set a target price of $46.0 on 08/12/2025
- Ashwani Verma from UBS set a target price of $38.0 on 07/30/2025
- Silvan Tuerkcan from JMP Securities set a target price of $50.0 on 07/29/2025
- Leonid Timashev from RBC Capital set a target price of $45.0 on 07/29/2025
$EXEL Insider Trading Activity
$EXEL insiders have traded $EXEL stock on the open market 15 times in the past 6 months. Of those trades, 0 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $EXEL stock by insiders over the last 6 months:
- PATRICK J. HALEY (EVP, Commercial) has made 0 purchases and 4 sales selling 170,770 shares for an estimated $8,003,594.
- CHRISTOPHER J. SENNER (EVP and CFO) sold 100,000 shares for an estimated $4,600,000
- AMY C. PETERSON (EVP Prod Dev & Med Aff & CMO) sold 72,776 shares for an estimated $3,309,124
- STELIOS PAPADOPOULOS has made 0 purchases and 2 sales selling 36,508 shares for an estimated $1,619,129.
- JEFFREY HESSEKIEL (EVP & General Counsel) sold 25,000 shares for an estimated $1,154,500
- GEORGE POSTE sold 20,634 shares for an estimated $948,957
- SUE GAIL ECKHARDT has made 0 purchases and 2 sales selling 18,838 shares for an estimated $805,139.
- JACK L WYSZOMIERSKI sold 7,535 shares for an estimated $324,683
- TOMAS J. HEYMAN sold 4,544 shares for an estimated $201,253
- DANA AFTAB (CSO/EVP Disc & Trans Research) sold 1,508 shares for an estimated $58,812
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EXEL Hedge Fund Activity
We have seen 345 institutional investors add shares of $EXEL stock to their portfolio, and 300 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FARALLON CAPITAL MANAGEMENT LLC removed 6,498,000 shares (-28.8%) from their portfolio in Q2 2025, for an estimated $286,399,350
- TWO SIGMA ADVISERS, LP removed 1,856,300 shares (-81.2%) from their portfolio in Q2 2025, for an estimated $81,816,422
- QUBE RESEARCH & TECHNOLOGIES LTD added 1,665,110 shares (+120.5%) to their portfolio in Q2 2025, for an estimated $73,389,723
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,580,567 shares (+42.9%) to their portfolio in Q2 2025, for an estimated $69,663,490
- ACADIAN ASSET MANAGEMENT LLC removed 1,520,175 shares (-81.7%) from their portfolio in Q2 2025, for an estimated $67,001,713
- PACER ADVISORS, INC. added 1,249,843 shares (+184.3%) to their portfolio in Q2 2025, for an estimated $55,086,830
- VANGUARD GROUP INC removed 1,202,893 shares (-4.2%) from their portfolio in Q2 2025, for an estimated $53,017,508
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
